Jazz Pharmaceuticals plc buy Piper Sandler
Start price
20.03.24
/
50%
€115.05
Target price
20.03.25
€173.30
Performance (%)
-11.08%
Price
26.04.24
€102.30
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -11.08%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.872% | -0.872% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Piper_Sandler for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Piper Sandler from $171.00 to $188.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat